Myocardial Tissue Engineering: the Quest for the Ideal Myocardial Substitute
Overview
Authors
Affiliations
There has been an intense and competitive quest to manufacture bioartificial heart muscle in the last decade. Numerous biocompatible scaffolds and scaffold-free systems, enriched with various cell types, have been used to fabricate 3D grafts for myocardial repair. In spite of the impressive achievements in the myocardial tissue-engineering field, many issues remain to be addressed before clinical application of this strategy becomes feasible. This is largely due to the uniqueness of the heart's structure and function. This review provides a survey upon the reported strategies, and indicates caveats and perspectives in the field of myocardial tissue engineering.
Kawamura M, Miyagawa S, Fukushima S, Saito A, Toda K, Daimon T Tissue Eng Part A. 2015; 21(15-16):2272-80.
PMID: 26046810 PMC: 4528991. DOI: 10.1089/ten.TEA.2014.0036.
Lilyanna S, Martinez E, Vu T, Ling L, Gan S, Tan A Tissue Eng Part A. 2013; 19(11-12):1303-15.
PMID: 23448654 PMC: 3638562. DOI: 10.1089/ten.tea.2012.0407.
Dawson J, Schussler O, Al-Madhoun A, Menard C, Ruel M, Skerjanc I In Vitro Cell Dev Biol Anim. 2011; 47(9):653-64.
PMID: 21938587 DOI: 10.1007/s11626-011-9453-0.
Yuan Ye K, Black 3rd L J Cardiovasc Transl Res. 2011; 4(5):575-91.
PMID: 21818697 PMC: 3182851. DOI: 10.1007/s12265-011-9303-1.
Mukherjee S, Gualandi C, Focarete M, Ravichandran R, Venugopal J, Raghunath M J Mater Sci Mater Med. 2011; 22(7):1689-99.
PMID: 21617996 DOI: 10.1007/s10856-011-4351-2.